(CWI) SPDR MSCI ACWI ex-US - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78463X8487

CWI: Large-Cap, Mid-Cap, International, Developed, Emerging

The SPDR MSCI ACWI ex-US ETF (CWI) is an investment vehicle that tracks the performance of large- and mid-cap equities in developed and emerging markets, excluding the United States. By investing at least 80% of its assets in the securities that comprise the underlying index, the fund provides broad exposure to international markets.

The underlying index is a free float-adjusted market capitalization index, meaning it represents the market value of the constituent securities, adjusted for the proportion of shares available for trading. This index is designed to capture the performance of a wide range of international equities, providing a comprehensive view of global markets outside the US.

From a technical analysis perspective, the current price of $32.35 is above its 20-day, 50-day, and 200-day simple moving averages (SMA20, SMA50, SMA200) of $31.57, $30.13, and $29.05, respectively. This indicates a bullish trend. The Average True Range (ATR) of 0.28, representing a 0.87% daily price movement, suggests relatively stable price action. Given the current price is at its 52-week high, and considering the upward trend indicated by the moving averages, a potential forecast could be a continued upward trajectory, potentially testing new highs.

Fundamentally, the Assets Under Management (AUM) of $1839.95M USD indicate a substantial investor base, contributing to the ETFs liquidity. The size and liquidity of the fund can make it an attractive option for investors seeking international exposure.

Combining technical and fundamental insights, a forecast for CWI could be that it continues to rise, driven by its bullish trend and supported by its significant AUM. However, investors should monitor the ATR and overall market conditions to adjust their strategies accordingly. A potential target could be a new 52-week high, with a stop-loss around the SMA20 or SMA50 levels to manage risk.

Additional Sources for CWI ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CWI ETF Overview

Market Cap in USD 1,839m
Category Foreign Large Blend
TER 0.30%
IPO / Inception 2007-01-10

CWI ETF Ratings

Growth Rating 56.3
Fundamental -
Dividend Rating 55.5
Rel. Strength 2.42
Analysts -
Fair Price Momentum 31.32 USD
Fair Price DCF -

CWI Dividends

Dividend Yield 12m 2.74%
Yield on Cost 5y 4.25%
Annual Growth 5y 7.12%
Payout Consistency 93.0%
Payout Ratio %

CWI Growth Ratios

Growth Correlation 3m 95.4%
Growth Correlation 12m 62.6%
Growth Correlation 5y 57.3%
CAGR 5y 10.54%
CAGR/Max DD 5y 0.36
Sharpe Ratio 12m 1.76
Alpha 6.94
Beta 0.750
Volatility 13.73%
Current Volume 132.2k
Average Volume 20d 234.8k
What is the price of CWI shares?
As of June 29, 2025, the stock is trading at USD 32.58 with a total of 132,183 shares traded.
Over the past week, the price has changed by +3.56%, over one month by +3.14%, over three months by +9.71% and over the past year by +18.45%.
Is SPDR MSCI ACWI ex-US a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, SPDR MSCI ACWI ex-US (NYSE ARCA:CWI) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.32 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CWI is around 31.32 USD . This means that CWI is currently overvalued and has a potential downside of -3.87%.
Is CWI a buy, sell or hold?
SPDR MSCI ACWI ex-US has no consensus analysts rating.
What are the forecasts for CWI share price target?
According to our own proprietary Forecast Model, CWI SPDR MSCI ACWI ex-US will be worth about 35.8 in June 2026. The stock is currently trading at 32.58. This means that the stock has a potential upside of +9.88%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 35.8 9.9%